Carbamazepine Oral Suspension
» Carbamazepine Oral Suspension contains not less than 90.0 percent and not more than 110.0 percent of the labeled amount of carbamazepine (C15H12N2O).
Packaging and storage Preserve in tight, light-resistant containers, protected from freezing and from excessive heat.
USP Reference standards 11
USP Carbamazepine RS.
Identification, Infrared Absorption 197S
Solution Place 5 mL of Oral Suspension in a separator containing 20 mL of 0.1 N sodium hydroxide, and extract with 25 mL of chloroform. Pass the extract through anhydrous sodium sulfate supported on filter paper into a beaker. Wash the anhydrous sodium sulfate with 10 mL of chloroform, and add the washing to the extract. Evaporate the chloroform extract with the aid of a stream of nitrogen to dryness. Dissolve the residue in 10 mL of methylene chloride.
Microbial enumeration tests 61 and Tests for specified microorganisms 62 The total bacterial count does not exceed 100 cfu per g, and the tests for Salmonella species and Escherichia coli are negative.
Uniformity of dosage units 905
for oral suspension packaged in single-unit containers: meets the requirements.
Deliverable volume 698
for oral suspension packaged in multiple-unit containers: meets the requirements.
Mobile phase, System suitability solution, Standard preparation, and Chromatographic system Prepare as directed in the Assay under Carbamazepine.
Assay preparation Transfer an accurately measured volume of freshly mixed Oral Suspension, equivalent to about 200 mg of carbamazepine, to a 100-mL volumetric flask, add about 70 mL of methanol, shake by mechanical means for about 30 minutes, sonicate for about 2 minutes, dilute with methanol to volume, and mix. Allow the solution to stand for about 10 minutes, transfer 10.0 mL of the clear solution to a 100-mL volumetric flask, dilute with methanol to volume, and mix. This is the final Assay preparation. For system suitability determination, transfer 10.0 mL of this solution to a suitable container, add 10.0 mL of System suitability solution, and mix.
Procedure Proceed as directed in the Assay under Carbamazepine. Calculate the quantity, in mg, of carbamazepine (C15H12N2O) in the portion of Oral Suspension taken by the formula:
10C(rU / rS)in which the terms are as defined therein.
Auxiliary Information Please check for your question in the FAQs before contacting USP.Chromatographic Column
USP32NF27 Page 1785Pharmacopeial Forum: Volume No. 29(6) Page 1857
Chromatographic columns text is not derived from, and not part of, USP 32 or NF 27.